2015
DOI: 10.1001/jamaophthalmol.2014.3544
|View full text |Cite
|
Sign up to set email alerts
|

Angiographic-Guided Treatment of Corneal Neovascularization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 0 publications
0
11
0
Order By: Relevance
“…The treatment for corneal neovascularization aims at the occlusion of aferent corneal blood vessels to reduce exudative lipid keratopathy, and stromal edema and inlammation or as a preoperative conditioning intervention before keratoplasty to increase chances of graft survival [17,43]. Current treatments for corneal neovascularization consist of topical nonsteroid anti-inlammatory and corticosteroid medications [44], photodynamic therapy [45], laser photocoagulation [46,47], ine needle diathermy [48], and limbal, conjunctival, and amniotic membrane transplantation (AMT) [49].…”
Section: Treatmentsmentioning
confidence: 99%
“…The treatment for corneal neovascularization aims at the occlusion of aferent corneal blood vessels to reduce exudative lipid keratopathy, and stromal edema and inlammation or as a preoperative conditioning intervention before keratoplasty to increase chances of graft survival [17,43]. Current treatments for corneal neovascularization consist of topical nonsteroid anti-inlammatory and corticosteroid medications [44], photodynamic therapy [45], laser photocoagulation [46,47], ine needle diathermy [48], and limbal, conjunctival, and amniotic membrane transplantation (AMT) [49].…”
Section: Treatmentsmentioning
confidence: 99%
“…An HRA2 Scanning Laser Ophthalmoscope (Heidelberg Engineering, Heidelberg, Germany) with a 20°imaging lens set at 34 diopters is used for indocyanine green angiography (ICGA) and fluorescein angiography as previously described. 13,14 It is important to note that in the healthy state, the vasculature surrounding the peripheral cornea and limbus fills in a distinctive pattern with the inferior (I) quadrant filling first, followed by the superior (S), nasal (N), and finally temporal (T) quadrants (the ISNT rule). 13 In addition, the age and cardiovascular status are important considerations in determining the time elapsed before commencement of the video recording for the appearance of dye in the afferent vessels.…”
Section: Protocolmentioning
confidence: 99%
“…13,14 It is important to note that in the healthy state, the vasculature surrounding the peripheral cornea and limbus fills in a distinctive pattern with the inferior (I) quadrant filling first, followed by the superior (S), nasal (N), and finally temporal (T) quadrants (the ISNT rule). 13 In addition, the age and cardiovascular status are important considerations in determining the time elapsed before commencement of the video recording for the appearance of dye in the afferent vessels. In a young person, dye would be expected to be seen approximately 10 seconds after injection, whereas in an elderly person the dye may not appear until after 25 seconds.…”
Section: Protocolmentioning
confidence: 99%
“…Therefore, one option is to treat only the afferent vessel(s) of the CoNV. 12 Although it is sometimes possible to distinguish afferent from efferent CoNV using slit-lamp biomicroscopy, it has been shown that the full extent and origin of the CoNV complex is not apparent on color images. 13e15 However, we have recently shown that corneal angiography (fluorescein angiography [FA] and indocyanine green angiography [ICGA]) are particularly useful in identifying vessels not seen on color images, 13e15 especially in the presence of corneal scars or inflammation, and facilitate identification and differentiation of afferent and efferent vessels and vessel leakage.…”
mentioning
confidence: 99%